ZURICH, Switzerland, Oct. 15, 2007 (PRIME NEWSWIRE) -- Nobel Biocare (Other OTC:NBCHF) today announced that with effect of 1 December 2007 Petra Rumpf (40) is appointed to the Executive Committee as Head of Business Development and Strategic Planning. She joins Nobel Biocare from CapGemini where she is Vice President and member of the Central European management team. As former head of the strategy unit in Central Europe and global head of M&A, Petra has gained extensive experience in strategy development, change management and M&A. Together with her team she recently won the 2007 ASCO (Swiss association of management consultants) award for the “Best Business Transformation”. Petra Rumpf is a German citizen and holds a degree in economics and an MBA from Clark University, Massachusetts (USA).
